Scoping review for pain mitigation during intralesional injections of corticosteroid for hypertrophic scar and keloid treatment.

ABSTRACT:

Background

Intralesional corticosteroid injection (ILCSI) has been proven to successfully treat hypertrophic scars (HTSs) and keloids and attain remission in 50% of keloids. Pain is a significant problem with ILCSI, which can affect treatment compliance and effectiveness. To date, many techniques involving ILCSI have been described and used to achieve scar treatment while reducing side effects. The injection technique remains the most widely available method in many healthcare centres.

Objective

This scoping review explores strategies for alleviating pain while administering ILCSIs for hypertrophic scarring and keloid management. ILCSI is a second-line treatment for HTSs and a first-line treatment for keloids.

Eligibility criteria

This scoping review included studies

SUBMITTER: Mardhiah J 

PROVIDER: S-EPMC11865806 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature